drugset / Trial / NCT04370145
Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy
RandomizedParallel-groupOpen-labelTreatment
Summary
Application of multi-center, prospective study on the severity of postoperative cholangitis biliary atresia classification, according to the degree of cholangitis targeted therapy, to improve the therapeutic effect of postoperative cholangitis biliary atresia, decrease the overuse of antibiotics related complications.
Timeline
- Start
- 2021-05-01
- Primary completion
- 2021-10-01
- Completion
- 2022-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Meropenem | Small molecule | 20 mg/kg | Intravenous |
| Subject | Sulperazon | Unknown | 100 mg/kg | Intravenous |
| Subject | Teicoplanin | Other / unclassified | 10 mg/kg | Intravenous |